DD277071A5 - Hydrozimtsaeurederivate - Google Patents

Hydrozimtsaeurederivate Download PDF

Info

Publication number
DD277071A5
DD277071A5 DD88318084A DD31808488A DD277071A5 DD 277071 A5 DD277071 A5 DD 277071A5 DD 88318084 A DD88318084 A DD 88318084A DD 31808488 A DD31808488 A DD 31808488A DD 277071 A5 DD277071 A5 DD 277071A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
hydrogen
compound
alkyl
mol
Prior art date
Application number
DD88318084A
Other languages
German (de)
English (en)
Inventor
Werner Aschwanden
Rene Imhof
Roland Jakob-Roetne
Emilio Kyburz
Original Assignee
�K@��������`��@�����@�K@��Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �K@��������`��@�����@�K@��Kk�� filed Critical �K@��������`��@�����@�K@��Kk��
Publication of DD277071A5 publication Critical patent/DD277071A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD88318084A 1987-07-21 1988-07-19 Hydrozimtsaeurederivate DD277071A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH276487 1987-07-21

Publications (1)

Publication Number Publication Date
DD277071A5 true DD277071A5 (de) 1990-03-21

Family

ID=4241087

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88318084A DD277071A5 (de) 1987-07-21 1988-07-19 Hydrozimtsaeurederivate

Country Status (25)

Country Link
US (2) US4883815A (ja)
EP (1) EP0300371A1 (ja)
JP (1) JPS6447748A (ja)
KR (1) KR890001954A (ja)
CN (1) CN1015622B (ja)
AU (1) AU603470B2 (ja)
DD (1) DD277071A5 (ja)
DK (1) DK405888A (ja)
FI (1) FI883441A (ja)
GB (1) GB2207135B (ja)
HU (1) HU198676B (ja)
IL (1) IL87130A0 (ja)
IN (1) IN167395B (ja)
IS (1) IS3376A7 (ja)
MC (1) MC1960A1 (ja)
MT (1) MTP1023B (ja)
MW (1) MW2688A1 (ja)
NO (1) NO883233L (ja)
NZ (1) NZ225442A (ja)
OA (1) OA08746A (ja)
PT (1) PT88041A (ja)
TN (1) TNSN88076A1 (ja)
YU (2) YU141488A (ja)
ZA (1) ZA885102B (ja)
ZW (1) ZW9288A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250539A (en) * 1991-08-21 1993-10-05 Eli Lilly And Company Hexahydrobenzo[f]quinolinones
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
ES2125884T3 (es) * 1991-08-21 1999-03-16 Lilly Co Eli Hexahidrobenzo(f)quinolinonas como inhibidores de la 5-alfa-reductasa.
US5574054A (en) * 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
US5849914A (en) * 1996-08-09 1998-12-15 Merck & Co., Inc. Compounds formed by an asymmetric conjugate addition reaction
US6172235B1 (en) 1996-08-09 2001-01-09 Merck & Co., Inc. Asymmetric conjugate addition reaction
CA2262837C (en) * 1996-08-09 2003-03-11 Richard D. Tillyer An asymmetric conjugate addition reaction
GB9920872D0 (en) 1999-09-04 1999-11-10 Glaxo Group Ltd Benzophenones as inhibitors of reverse transcriptase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795683A (en) * 1970-08-19 1974-03-05 Hoffmann La Roche 2,3,4,5-tetrahydro-1h-3-benzazepines
JPS6033439B2 (ja) * 1980-03-07 1985-08-02 財団法人相模中央化学研究所 ジペプチドの製造方法
IT1175926B (it) * 1984-01-13 1987-08-12 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina
DE3773950D1 (de) * 1986-01-23 1991-11-28 Hoffmann La Roche Benzazecin-derivate.

Also Published As

Publication number Publication date
IN167395B (ja) 1990-10-20
KR890001954A (ko) 1989-04-06
CN1036952A (zh) 1989-11-08
OA08746A (fr) 1989-03-31
DK405888D0 (da) 1988-07-20
US5017608A (en) 1991-05-21
MTP1023B (en) 1989-07-18
YU141488A (en) 1990-06-30
HU198676B (en) 1989-11-28
JPS6447748A (en) 1989-02-22
NO883233D0 (no) 1988-07-20
TNSN88076A1 (fr) 1990-07-10
FI883441A0 (fi) 1988-07-20
DK405888A (da) 1989-01-22
NZ225442A (en) 1991-05-28
EP0300371A1 (de) 1989-01-25
ZA885102B (en) 1989-03-29
MC1960A1 (fr) 1989-06-30
GB2207135A (en) 1989-01-25
YU39890A (en) 1991-10-31
GB8817291D0 (en) 1988-08-24
GB2207135B (en) 1991-05-15
MW2688A1 (en) 1989-04-12
FI883441A (fi) 1989-01-22
US4883815A (en) 1989-11-28
AU603470B2 (en) 1990-11-15
IS3376A7 (is) 1989-01-22
NO883233L (no) 1989-01-23
AU1917688A (en) 1989-01-27
HUT47077A (en) 1989-01-30
ZW9288A1 (en) 1989-02-01
IL87130A0 (en) 1988-12-30
CN1015622B (zh) 1992-02-26
PT88041A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
DE2824064A1 (de) Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel
DE69013959T2 (de) Aminobenzolsulfonsäurederivate.
DE3889302T2 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE69027180T2 (de) 4-Acylaminopyridin-Derivate
EP0230967B1 (de) Benzazecin-Derivate
DE2740562A1 (de) Optisch aktive azabicyclohexane, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DD277071A5 (de) Hydrozimtsaeurederivate
DE2015568B2 (de) S^-Dimethoxyindazol-S-carbonsäureamide
EP0250361B1 (de) Disubstituierte Piperazine
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE2414751A1 (de) Neue 4h-pyrido-eckige klammer auf 1,2a eckige klammer zu-pyrimidin-derivate und verfahren zur herstellung derselben
EP0170861B1 (de) 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4117750A1 (de) Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CH651554A5 (de) Schwefelhaltige isochinolinderivate, verfahren zur herstellung derselben und die diese verbindungen enthaltenden pharmazeutischen zubereitungen.
EP0123700A1 (de) Substituierte Picolinsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
EP0472166A1 (de) Tricyclische Pyridonderivate
DE2409791C3 (de) Derivate von 2-Aminoindan und'sie enthaltende Arzneimittel
DE2308064C3 (de) Benzotriazole, ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine
EP0643045B1 (de) Chinolin-Verbindungen als Leukotriene Antagonisten
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
DE1695080A1 (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
AT346841B (de) Verfahren zur herstellung von neuen 3- phenylindolinen und ihren salzen
AT212318B (de) Verfahren zur Herstellung von neuen Phenthiazinderivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee